Dezentjé, V. O., Opdam, F. L., Gelderblom, H., Hartigh den, J., Van der Straaten, T., Vree, R., . . . Guchelaar, H. (2015). CYP2D6 genotype- and endoxifen-guided tamoxifen dose escalation increases endoxifen serum concentrations without increasing side effects. Breast Cancer Res Treat.
Chicago Stili AlıntıDezentjé, V. O., et al. "CYP2D6 Genotype- and Endoxifen-guided Tamoxifen Dose Escalation Increases Endoxifen Serum Concentrations Without Increasing Side Effects." Breast Cancer Res Treat 2015.
MLA AlıntıDezentjé, V. O., et al. "CYP2D6 Genotype- and Endoxifen-guided Tamoxifen Dose Escalation Increases Endoxifen Serum Concentrations Without Increasing Side Effects." Breast Cancer Res Treat 2015.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..